BIOCHEMISTRY OF LEUKEMIA VIRUS CORE BINDING FACTOR
BIOCHEMISTRY OF LEUKEMIA VIRUS CORE BINDING FACTOR
批准号:
6475801
负责人:
NANCY SPECK
金额:
$36.26万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1993
资助国家:
美国
项目状态:
已结题
起止时间:
1993-08-10 至 2003-03-31
关键词:
DNA binding protein cell differentiation chimeric proteins chromosome translocation conformation dimer embryonic stem cell gene mutation genetic transcription genetically modified animals hematopoiesis histology laboratory mouse murine leukemia virus oncoproteins protein binding protein structure function tissue /cell culture transcription factor viral leukemia viral leukemogenesis virus protein
中文摘要
核心结合因子(CBF)是一种异源二聚体转录因子
在造血中起核心作用的复合体。 我们对CBF的兴趣
开始于我们的发现,在CBF结合位点的突变,
莫洛尼鼠白血病病毒增强子改变疾病特异性
从T细胞淋巴瘤到红系白血病的莫洛尼MLV。 进行纯化
来自小牛胸腺的CBF,编码CBF复合物的克隆cDNA,和
证明CBF由DNA结合亚基(CBF α)组成,
和非DNA结合亚基(CBF β)。 基因编码两种
CBF α和CBF β亚基被染色体
与人类急性白血病相关的易位。 CBFA2
编码CBF α亚基的AML 1基因被
t(8;21)、t(12:21)和t(3;21)在急性髓系和淋巴细胞白血病中的表达
白血病,以及治疗相关的白血病和骨髓增生异常。 的
CBFB基因编码非DNA结合的CBF β亚基,
在急性髓性白血病中被inv破坏(16)。 这些易位
导致嵌合蛋白质的合成,
结合到DNA中的CBF靶位点,在那里它们可能会解除对CBF的调节。
CBF靶基因的表达和阻断分化
造血细胞 CBFA 2(AML 1)和CBFB基因共同作用,
在大约三分之一的新生急性白血病中被破坏,
使它们成为人类白血病中最常被破坏的基因。 我们
通过突变Cbfa 2证实了CBF在造血中的重要性,
和Cbfb基因,并证明这两种突变完全
破坏体内造血功能。我们还生成了胚胎
Cbfa 2和Cbfb基因突变纯合的干(ES)细胞,
并表明这些胚胎干细胞不能分化成
在体外或嵌合小鼠中的永久造血细胞。
该建议集中在DNA结合CBFalpha 2亚基上。 我们的整体
目的是表征CBFalpha 2亚基的功能结构域
及其致癌衍生物(特定目标1),以确定三个
CBFalpha 2 DNA结合结构域的三维结构(特异性目的
2),并表征细胞和分子基础,
在Cbfa 2 -1-小鼠中观察到的发育缺陷(具体目标3)。 采取
总之,这些实验将提供详细的结构和
CBFalpha 2蛋白功能结构域的生化信息
及其致癌衍生物,并将进一步我们的理解,
CBF在正常发育和白血病中的作用。
英文摘要
The core-binding factor (CBF) is a heterodimeric transcription factor
complex that plays a central role in hematopoiesis. Our interest in CBF
began with our discovery that a mutation in the CBF binding site in the
Moloney murine leukemia virus enhancer changes the disease specificity
of Moloney MLV from T cell lymphoma to erythroid leukemia. We purified
CBF from calf thymus, cloned cDNAs encoding the CBF complex, and
demonstrated that CBF is comprised of a DNA-binding subunit (CBFalpha),
and a non-DNA-binding subunit (CBFbeta). Genes encoding both the
CBFalpha and CBFbeta subunits are disrupted by chromosomal
translocations associated with acute leukemias in humans. The CBFA2
(AML1) gene, which encodes a CBFalpha subunit, is disrupted by the
t(8;21), t(12:21) and t(3;21) in acute myeloid and lymphocytic
leukemias, and in therapy related leukemias and myelodysplasias. The
CBFB gene, which encodes the non-DNA-binding CBFbeta subunit, is
disrupted in acute myeloid leukemias by inv(16). These translocations
result in the synthesis of chimeric proteins that retain the ability to
bind to CBF target sites in DNA, where presumably they deregulate the
expression of CBF target genes and block differentiation of
hematopoietic cells. Together, the CBFA2 (AML1) and CBFB genes are
disrupted in approximately one third of all de novo acute leukemias,
making them the most frequently disrupted genes in human leukemias. We
confirmed the importance of CBF in hematopoiesis by mutating the Cbfa2
and Cbfb genes in mice, and demonstrating that both mutations completely
disrupt definitive hematopoiesis in vivo. We also generated embryonic
stem (ES) cells homozygous for mutations in the Cbfa2 and Cbfb genes,
and showed that these ES cells are incapable of differentiating into
definitive hematopoietic cells either in vitro, or in chimeric mice.
This proposal focuses on the DNA-binding CBFalpha2 subunit. Our overall
goals are to characterize functional domains in the CBFalpha2 subunit
and its oncogenic derivatives (Specific Aim 1), to determine the three
dimensional structure of the CBFalpha2 DNA-binding domain (Specific Aim
2), and to characterize the cellular and molecular basis for the
developmental defects seen in Cbfa2-1-mice (Specific Aim 3). Taken
together, these experiments will provide detailed structural and
biochemical information on functional domains of the CBFalpha2 protein
and its oncogenic derivatives, and will further our understanding of the
role of CBF in normal development and leukemia.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Repressing TGFbeta family signaling to promote hematopoietic stem cell formation in the embryo
-
批准号:10589924
-
项目类别:
-
资助金额:$34.32万
-
财政年份:2022
-
负责人:NANCY SPECK
-
依托单位:
Mechanisms of endothelial-to-hemogenic transition mediated by Runx1
-
批准号:9922673
-
项目类别:
-
资助金额:$38.08万
-
财政年份:2017
-
负责人:NANCY SPECK
-
依托单位:
CD27:CD70 signaling in hematopoietic stem cell formation
-
批准号:9374787
-
项目类别:
-
资助金额:$20.78万
-
财政年份:2017
-
负责人:NANCY SPECK
-
依托单位:
Mechanisms of endothelial-to-hemogenic transition mediated by Runx1
-
批准号:9547467
-
项目类别:
-
资助金额:$47.17万
-
财政年份:2017
-
负责人:NANCY SPECK
-
依托单位:
Mechanisms of endothelial-to-hemogenic transition mediated by Runx1
-
批准号:10183274
-
项目类别:
-
资助金额:$37.32万
-
财政年份:2017
-
负责人:NANCY SPECK
-
依托单位:
Epigenetic landscapes of embryonic lymphoid progenitors and HSCs
-
批准号:9061765
-
项目类别:
-
资助金额:$23.17万
-
财政年份:2015
-
负责人:NANCY SPECK
-
依托单位:
Epigenetic landscapes of embryonic lymphoid progenitors and HSCs
-
批准号:8891754
-
项目类别:
-
资助金额:$20.92万
-
财政年份:2015
-
负责人:NANCY SPECK
-
依托单位:
Regulation of hematopoietic stem cell and progenitor cell proliferation by Runx1
-
批准号:8782253
-
项目类别:
-
资助金额:$33.2万
-
财政年份:2011
-
负责人:NANCY SPECK
-
依托单位:
Regulation of hematopoietic stem cell and progenitor cell proliferation by Runx1
-
批准号:8050470
-
项目类别:
-
资助金额:$33.2万
-
财政年份:2011
-
负责人:NANCY SPECK
-
依托单位:
Regulation of hematopoietic stem cell and progenitor cell proliferation by Runx1
-
批准号:8588296
-
项目类别:
-
资助金额:$32.2万
-
财政年份:2011
-
负责人:NANCY SPECK
-
依托单位:
Regulation of hematopoietic stem cell and progenitor cell proliferation by Runx1
-
批准号:8208990
-
项目类别:
-
资助金额:$33.2万
-
财政年份:2011
-
负责人:NANCY SPECK
-
依托单位:
Regulation of hematopoietic stem cell and progenitor cell proliferation by Runx1
-
批准号:8408770
-
项目类别:
-
资助金额:$31.21万
-
财政年份:2011
-
负责人:NANCY SPECK
-
依托单位:
FASEB Conference-Hematological Malignancies
-
批准号:7001073
-
项目类别:
-
资助金额:$1.0万
-
财政年份:2005
-
负责人:NANCY SPECK
-
依托单位:
Runx1 as a Marker for Stem Sells
-
批准号:6798311
-
项目类别:
-
资助金额:$45.06万
-
财政年份:2003
-
负责人:NANCY SPECK
-
依托单位:
Runx1 as a Marker for Stem Sells
-
批准号:6579275
-
项目类别:
-
资助金额:$16.04万
-
财政年份:2003
-
负责人:NANCY SPECK
-
依托单位:
Runx1 as a Marker for Stem Sells
-
批准号:6838248
-
项目类别:
-
资助金额:$46.27万
-
财政年份:2003
-
负责人:NANCY SPECK
-
依托单位:
Runx1 as a Marker for Stem Sells
-
批准号:7009258
-
项目类别:
-
资助金额:$46.39万
-
财政年份:2003
-
负责人:NANCY SPECK
-
依托单位:
MOUSE MODELS FOR FAMILIAL PLATELET DISORDER
-
批准号:6692649
-
项目类别:
-
资助金额:$29.48万
-
财政年份:2001
-
负责人:NANCY SPECK
-
依托单位:
MOUSE MODELS FOR FAMILIAL PLATELET DISORDER
-
批准号:6626790
-
项目类别:
-
资助金额:$31.45万
-
财政年份:2001
-
负责人:NANCY SPECK
-
依托单位:
MOUSE MODELS FOR FAMILIAL PLATELET DISORDER
-
批准号:6231273
-
项目类别:
-
资助金额:$32.2万
-
财政年份:2001
-
负责人:NANCY SPECK
-
依托单位:
海外基金